Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 27.28
+0.20 (0.74%)
Apr 29, 2026, 12:54 PM CET
Hansa Biopharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -691.58 | -534.11 | -807.24 | -831.72 | -611.13 | -548.28 | Upgrade
|
| Depreciation & Amortization | 10.32 | 10.32 | 10.09 | 10.74 | 9.96 | 6.51 | Upgrade
|
| Other Amortization | 28.44 | 28.44 | 17.98 | 9.05 | 2.09 | 2.09 | Upgrade
|
| Stock-Based Compensation | 34.79 | 34.79 | 31.69 | 60.64 | 58.23 | 56.62 | Upgrade
|
| Other Operating Activities | 99.27 | -51 | 136.64 | -15.8 | 16.69 | -1 | Upgrade
|
| Change in Accounts Receivable | -35.16 | -35.16 | -66.94 | -35.07 | -33.25 | -9.6 | Upgrade
|
| Change in Accounts Payable | 16.44 | 16.44 | -49.35 | 24.49 | 9.12 | 28.58 | Upgrade
|
| Change in Other Net Operating Assets | -16.8 | -18.89 | 52.26 | 22.01 | 45.56 | -16.09 | Upgrade
|
| Operating Cash Flow | -554.28 | -549.17 | -674.88 | -755.65 | -502.73 | -481.17 | Upgrade
|
| Capital Expenditures | - | - | -0.12 | -0.28 | -3.33 | -2.4 | Upgrade
|
| Investment in Securities | - | - | - | - | 232.64 | - | Upgrade
|
| Investing Cash Flow | - | - | -0.12 | -0.28 | 229.31 | -2.4 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 736.4 | - | Upgrade
|
| Long-Term Debt Repaid | - | -17.64 | -7.5 | -7.55 | -6.89 | -4.86 | Upgrade
|
| Net Debt Issued (Repaid) | 116.16 | -17.64 | -7.5 | -7.55 | 729.51 | -4.86 | Upgrade
|
| Issuance of Common Stock | 903.6 | 903.6 | 372.15 | - | 415.95 | - | Upgrade
|
| Other Financing Activities | -37.9 | -38 | -17.85 | - | -27.78 | - | Upgrade
|
| Financing Cash Flow | 981.86 | 847.96 | 346.81 | -7.55 | 1,118 | -4.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.31 | -2.99 | 1.42 | -0.64 | 0.58 | 0.4 | Upgrade
|
| Net Cash Flow | 426.26 | 295.8 | -326.78 | -764.12 | 844.84 | -488.02 | Upgrade
|
| Free Cash Flow | -554.28 | -549.17 | -675 | -755.94 | -506.06 | -483.57 | Upgrade
|
| Free Cash Flow Margin | -290.98% | -247.08% | -394.01% | -563.74% | -327.50% | -1427.38% | Upgrade
|
| Free Cash Flow Per Share | -6.18 | -6.76 | -10.74 | -14.39 | -11.27 | -10.87 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 1.17 | - | Upgrade
|
| Cash Income Tax Paid | 2.57 | 2.38 | 3.61 | 0.13 | 1.57 | 0.14 | Upgrade
|
| Levered Free Cash Flow | -348.14 | -345.68 | -423.66 | -438.91 | -282.34 | -257.8 | Upgrade
|
| Unlevered Free Cash Flow | -208.51 | -269.12 | -339.86 | -372.96 | -255.05 | -257.36 | Upgrade
|
| Change in Working Capital | -35.51 | -37.61 | -64.03 | 11.44 | 21.43 | 2.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.